Raymond J. Bergeron

Internationally recognized as a pioneer of iron chelator technology, Dr. Raymond Bergeron is Chief Scientific Officer and a founder of AbFero Pharmaceuticals. Dr. Bergeron is Professor Emeritus, Medicinal Chemistry and Duckworth eminent scholar of drug development, University of Florida, and is a Charter Fellow of the National Academy of Inventors (NAI). Dr. Bergeron has dedicated his career to drug discovery and development in iron overload diseases and cancer with prolific results: he has published more than 200 papers, generated more than 200 patents, and six of his discoveries have reached human clinical trials. Dr. Bergeron graduated from Clark University, earned his PhD in chemistry from Brandeis University, and was a post-doctoral fellow with Nobel Laureate Konrad Bloch at Harvard University.